Status:
COMPLETED
Magnesium After Alcohol Withdrawal Treatment
Lead Sponsor:
Finnish Foundation for Alcohol Studies
Conditions:
Alcohol-Induced Disorders
Eligibility:
All Genders
20-64 years
Phase:
PHASE4
Brief Summary
The primary purpose is to see if magnesium tablet supplementation will decrease elevated GGT enzyme activity in alcoholic patients immediately after they had been treated for alcohol withdrawal. The s...
Detailed Description
Magnesium (Mg) deficiency is common among alcoholics. Animal studies have shown that magnesium deficiency aggravates the hepatic damage caused by alcohol. One study on chronic alcoholics suggested tha...
Eligibility Criteria
Inclusion
- Admission to treatment because of an acute alcohol withdrawal
- Elevated serum GGT (men\>80, women \>50)
- Age 20-64 years
- Fixed address and a telephone to facilitate follow-up
Exclusion
- Mg supplementation within the past two months ten 250 mg tablets or more
- History of heart rhythm disturbances
- Contraindications against Mg treatment
- Abnormally high serum creatinine
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT00325299
End Date
September 1 2005
Last Update
May 12 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Finnish Foundation for Alcohol Studies
Helsinki, Finland, 00531